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Delayed Hypoxemia after Traumatic Brain Injury
Exacerbates Long-Term Behavioral Deficits
McKenzie Davies,1 Addison Jacobs,1 David L. Brody,2 and Stuart H. Friess1
Abstract
Hypoxemia during initial stabilization of patients with severe traumatic brain injury (TBI) has been associated with poorer
outcomes. However, the effects of delayed hypoxemia occurring during intensive care post-TBI on outcome is unclear.
Pre-clinical models of TBI have rarely shown cognitive or behavioral deficits beyond 6 weeks post-injury and commonly
have not included modeling of secondary insults. We have previously developed a murine model of TBI followed by
delayed hypoxemia to model the secondary insult of hypoxemia and brain hypoxia occurring in the intensive care setting.
Understanding long-term effects of delayed hypoxemia post-TBI in our murine model is critical for future testing of
candidate therapeutics targeting secondary brain hypoxia. For this study, forty 5-week-old male mice were randomized to
controlled cortical impact (CCI; N= 24) or sham surgery (N = 16). One day later, awake animals were randomized to
60min of hypoxemia or normoxemia. Six months after initial injury, animals underwent behavior testing (Morris water
maze, social interaction, and tail suspension) before euthanasia for immunohistochemistry (IHC) assessments. At 6
months post-injury, mice experiencing CCI and hypoxemia (CCI+H) had longer swim distances to the hidden platform
(51 cm) compared to CCI alone (26 cm) or sham animals (22 cm). During social interaction assessments, CCI +H mice
spent less time interacting with novel stimulus mice (79 sec) than CCI alone (101 sec) or sham animals (139 sec). CCI +H
had larger lesion volumes compared to CCI alone (14.0% vs. 9.9%; p < 0.003). Glial fibrillary acidic protein IHC at 6
months post-injury demonstrated increased astrogliosis in the ipsilateral white matter of CCI +H compared to CCI alone.
To summarize, this clinically relevant model of delayed hypoxia post-TBI resulted in long-term behavioral deficits and
evidence of exacerbated structural injury.
Keywords: controlled cortical impact; delayed hypoxemia; long-term behavior; secondary injury; traumatic brain injury
Introduction
Traumatic brain injury (TBI)morbidity continues to be highdespite advances in medical care.1 One of the primary goals
of intensive care management of patients with severe TBI is the
prevention or amelioration of secondary insults such as hypox-
emia, hypotension, and intracranial hypertension, among others.
Hypoxemia occurring in the pre-hospital or emergency room
setting post-TBI has been associated with poorer outcomes.2–5
Previous investigations of pre-clinical models of hypoxemia im-
mediately post-TBI have demonstrated exacerbations in brain
edema and ischemia, hippocampal neuronal cell death, neuroin-
flammation, axonal injury, and short-term behavioral deficits.6–9
After initial stabilization, patients with severe TBI are at high risk
of exposure to delayed hypoxemia in the intensive care setting
attributed to pulmonary contusions, aspiration, pneumonia, atel-
ectasis, and acute respiratory distress syndrome. Small retro-
spective studies have observed that hypoxemia within the first
24 h post-injury is common and is associated with an increase in
mortality.10,11
Survivors of TBI may have lifelong impairments in cognition
and behavior.12–14 Pre-clinical investigations with various animal
models of TBI have improved our understanding of TBI patho-
physiology and have been utilized to identify promising candidate
neuroprotective therapeutics.15,16 However, the majority of animal
models of TBI have not been shown to have cognitive or behavioral
deficits beyond 6 weeks post-injury, whereas outcome measures in
clinical trials of therapeutics for TBI are typically performed 6–12
months post-injury.17–22 We have previously developed a murine
model of TBI followed by delayed hypoxemia to model the sec-
ondary insult of hypoxemia and brain hypoxia occurring in the
intensive care setting.11 We observed exacerbation of white matter
injury in mice experiencing TBI and delayed hypoxemia compared
with TBI alone at two different time points: 48 h and 1 week post-
injury. In our current investigations, we tested the hypothesis that
delayed hypoxemia following controlled cortical impact (CCI) in
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young mice (5 weeks old) would exacerbate long-term behavioral
deficits and neuropathology 6 months after initial injury.
Methods
Traumatic brain injury
All procedures were approved by the Washington University
Animal Studies Committee (Protocol 2014003) and are consistent
with the National Institutes of Health guidelines for the care and use
of animals. Animals were housed 5/cage and had free access to
water and food with 12-h light/dark cycle. Forty C57BL/6J 5-week-
old male mice ( Jackson Laboratory, Bar Harbor, ME) weighing
15–22.5 g were used (Fig. 1). Two mice were excluded because of
excessive brain swelling after craniectomy. Fourteen mice under-
went sham injury, and 24 mice underwent CCI as previously de-
scribed.11,23 Briefly, mice were anesthetized with 5% isoflurane at
induction, followed by maintenance at 2% isoflurane for the du-
ration of the procedure. Buprenorphine (50lg/kg subcutaneously
s.c.) was administered before scalp incision. The head was shaved
and head holders were used to stabilize the head within the ste-
reotaxic frame (MyNeurolab, St. Louis, MO). Then, a single 5-mm
craniectomy was performed by an electric drill on the left lateral
side of the skull centered 2.7mm lateral from the midline and 3mm
anterior to lambda. Animals were randomized to sham or injury
after craniectomy using a computer-generated numbers randomi-
zation. For injured animals, the 3-mm electromagnetic impactor tip
was then aligned with the craniectomy site at 1.2mm left of mid-
line, 1.5mm anterior to the lambda suture. The impact was then
delivered at 2mm depth (velocity 5m/s, dwell time 100ms). The
head holders were released immediately after the injury. All ani-
mals then received a loose fitting plastic cap secured over the
craniectomywith Vetbond (3M, St. Paul, MN). The skin was closed
with interrupted sutures and treated with antibiotic ointment before
removing the mouse from anesthesia and allowing recovery on a
warming pad. Two mice died immediately post-CCI.
Delayed hypoxemia
One day after sham surgery or CCI, animals were randomized to
normoxemia (room air) or hypoxemia (8%O2, 4%CO2) for 60min.
Amixture of N2, O2, and CO2 was utilized to maintain normocarbic
hypoxemia.11 We have previously demonstrated that these condi-
tions produce normocarbic hypoxemia in awake mice 24 h post-
CCI or sham surgery.11 During normoxemia or hypoxemia, animals
were placed in fresh cages with littermates randomized to the same
treatment arm. All animals were subjected to identical transport
and handling regardless of group assignment. Animals randomized
to hypoxemia were placed in a Coy Labs Hypoxia Chamber
(6¢ · 3¢ · 4¢; Coy Laboratory, Grass Lake, MI), fitted with airlock,
oxygen sensor, carbon dioxide sensor, and gas controllers.
Behavioral tests
Animals underwent behavioral testing 6 months after sham
surgery or CCI. All tests were conducted by an experimenter
blinded to group assignment. The order of tests was social inter-
action, Morris water maze, then tail suspension. All testing was
performed during the first 4 h of the light cycle.
Social interaction
The social interaction test was adapted and modified from pre-
vious reports.21,24 Animals were individually housed for at least 1 h
in the testing room for acclimation before testing. A 5-week-old
male stimulus mouse was introduced for a 5-min observation
FIG. 1. Experimental cohort design. All animals underwent craniectomy and were excluded from the study if brain swelling after the
procedure was excessive. Animals were randomized to sham or CCI using a computer-generated numbers randomization. Twenty-four
hours post-surgery, animals were randomized to 60min of normoxemia or hypoxemia. Behavioral assessments followed by histological
analysis were performed at 6 months. CCI, controlled cortical impact.















































period. A juvenile mouse was used to decrease the risk of aggres-
sive behavior during the test period. Stimulus mice were used for no
more than five social interaction sessions with a minimum time
interval of 30min between each session. A blinded observer scored
interaction initiated by the test mouse, excluding interaction initi-
ated by the stimulus mouse. Behaviors scored as interaction include
sniffing with the nose within 1 cm of the stimulus mouse (including
nose, body, and anogenital area), pawing and climbing on the
stimulus mouse, and following within 2 cm of the stimulus mouse.
Morris water maze
A platform 11 cm in diameter and a pool 109 cm in diameter in
a testing room with set visual cues were used as previously de-
scribed.23 Animals were tested in two cohorts of 20 to maximize
accuracy and ensure consistent latency times between trials. Each
animal underwent four trials per day for 3 days of visible platform
training, in order to control for differences in swim speed and visual
acuity. No trial lasted more than 60 sec, and the animal was allowed
to remain on the platform for 30 sec after completing the trial. After
3 days of rest, each animal underwent four trials per day for 5 days
of hidden platform training. The visual cues were reset before
hidden platform training. The platform was moved to a different
quadrant and hidden slightly below the waterline after the water had
been made opaque using nontoxic white tempera paint. On the final
day, the platform was removed from the pool after the completion
of hidden platform trials, and a 30-sec probe trial was conducted.
Tail suspension
The tail suspension test was adapted from previous investiga-
tions.21,25 Each animal was suspended with tape from a horizontal
rod elevated 30 cm above a clean cage for 6min. To prevent mice
from climbing their tails, a cardstock paper cone was placed around
the tail before suspension. The cones were 4.5 cm in diameter and
5.5 cm tall. A new cone was used for each mouse. A blinded ob-
server recorded the total time each mouse was immobile during the
6-min testing period. Immobility included motionless time as well
as passive swinging caused by momentum from movement.
Immunohistochemistry
Mice were killed under isoflurane anesthesia by transcardial
perfusion with 0.3% heparin in phosphate-buffered saline. Whole
brains were removed and fixed in 4% paraformaldehyde for 48 h,
followed by equilibration in 30% sucrose for at least 48 h before
sectioning. Serial 50-lm-thick coronal slices were cut on a freezing
microtome starting with the appearance of a complete corpus cal-
losum and caudally to bregma -3.08mm. Sets of 12 sections spaced
every 300 lm were mounted on glass slides and used for immu-
nohistochemical studies.
Staining was performed on free-floating sections washed in
Tris-buffered saline (TBS) between applications of primary and
secondary antibodies. Endogenous peroxidase was blocked by in-
cubating the tissue in TBS +0.3% hydrogen peroxide for 10min.
Normal goat serum (3%) in TBSwith 0.25% Triton X (TBS-X) was
used to block nonspecific staining for all antibodies. Slices were
then incubated at 4C overnight with one of the following primary
antibodies: polyclonal rabbit anti-glial fibrillary acidic protein
(GFAP; Dako North America, Carpinteria, CA) at a concentration
of 1:1000, polyclonal rabbit anti-neuronal nuclei (NeuN; EMD
Millipore, Billerica, MA) at a concentration of 1:4000, or poly-
clonal rabbit anti-ionized calcium binding adapter molecule 1
(Iba1;Wako Chemicals USA, Richmond, VA) at a concentration of
1:1000. Biotinylated goat antirabbit secondary antibodies (Vector
Laboratories, Burlingame, CA) in TBS-X were used at a 1:1000
concentration to detect bound primary antibodies. Colorization was
achieved using the Vectastain ABC Elite Kit (Vector Laboratories)
followed by the application of 3-3¢-diaminobenzidine (Sigma-
Aldrich, St. Louis, MO).
Quantification of immunohistochemistry
Extent of tissue loss in the ipsilateral hemisphere for each animal
was quantified using images of NeuN-stained slices acquired using
Hamamatsu NanoZoomer 2.0-HT System (Hamamatsu Corpora-
tion, Middlesex, NJ). Tissue loss in the injured hemisphere was
calculated as a percentage of the tissue volume in the contralateral
hemisphere as described by others.26
For GFAP measurements, 5 · images of the ipsilateral corpus
callosum and external capsule were obtained using the NanoZoo-
mer. Using ImageJ (NIH, Bethesda, MD), files were converted to
32-bit images, and positive signal on each image was selected using
the Max Entropy auto thresholding method. Regions of interest
(ROIs) began with the most anterior slice containing hippocampal
dentate gyrus and ended with the most posterior section containing
corpus callosum fibers that cross the midline, yielding three to four
sections for analysis per animal. The midline served as the medial
boundary for the ROI, and the lateral boundary was formed by
drawing a horizontal line between the ventral hippocampus and
dorsal thalamus in each section. Total area of ROIs and area of
positive thresholding from each slice were calculated and summed
to determine total percent area of positive GFAP staining.
Stereological analysis was performed using StereoInvestigator
software (version 8.2; MBF Bioscience, Williston, VT). Assess-
ments were made by an investigator blinded to group assign-
ment. The optical fractionator function was used to quantify
target markers per cubic millimeter of tissue. For quantification
of hippocampal neuronal loss in the CA3 region, a grid size of
250· 250lm, a counting frame of 40· 40lm, and a dissector height
of 15lmwith a guard zone of 5lmwere used for all quantifications,
resulting in 3% of the ROIs being randomly sampled. All ROIs were
traced at 4·magnification, and markers were counted at 60·mag-
nification.
For stereological quantification of Iba1-positive cells, the opti-
cal fractionator function was again used, with a grid size of
180 · 180lm and a counting frame of 80 · 80 lm. The ROI began
with the most anterior slice containing hippocampal dentate gyrus
and ended with the most posterior section containing corpus cal-
losum fibers that cross midline, which yielded three to four sections
for analysis per animal. The midline served as the medial boundary
for the ROI, whereas the lateral boundary was formed by drawing a
horizontal line between the ventral hippocampus and dorsal thal-
amus in each coronal section. Gunderson’s coefficients of error
were <0.1 for all stereological quantifications. All post-processing
and automated quantification algorithms are freely available upon
request.
Statistical analysis
All data were analyzed using Statistica (version 12; Dell Inc.,
Tulsa, OK). Data results are presented as mean– standard devia-
tion. There was no evidence for significant deviations from normal
distribution ( p> 0.05 by Shapiro-Wilk tests). Data were analyzed
with two-way analysis of variance with repeated measures, where
necessary, followed by Tukey’s tests for multiple comparisons with
a significance level of p< 0.05. Effect size between CCI and
CCI +H was calculated utilizing Cohen’s d.27
Results
Experimental cohort
Mice were randomized to one of four groups as described
above: sham (SHAM), sham+hypoxemia (SHAM+H), CCI, and
CCI+hypoxemia (CCI+H; Fig. 1). At the time of surgery, there was
no statistically significant difference between the weights or an-
esthesia times of the groups (Table 1). However, at the time of
sacrifice, CCI +H weighed less than SHAM (Table 1).















































Effects of delayed hypoxemia after traumatic brain
injury on socialization and depression-like symptoms
To determine the effect of delayed hypoxemia on socialization,
we conducted social interaction tests 6 months post-injury. Injury
and hypoxemia decreased social behaviors (Fig. 2A). Both injury
status (F1, 32 = 33.4; p = 0.000002) and hypoxemia (F1, 32 = 17.9;
p = 0.0002) had a significant impact on socialization. The CCI +H
group interacted with the stimulus mouse significantly less than the
SHAM ( p= 0.0002), SHAM +H ( p = 0.003), or CCI ( p = 0.027)
groups. The SHAM +H ( p = 0.023) and CCI ( p = 0.0008) groups
also interacted with the novel mouse significantly less than the
SHAM group. We observed a large effect size between CCI and
CCI +H (Cohen’s d= 1.2).
In order to determine the impact of our injury model on long-term
depression-like behaviors, we conducted tail suspension tests 6months
post-injury. Both injury and hypoxemia increased periods of im-
mobility (Fig. 2B). Injury status (F1, 32=11.3, p=0.002), hypoxemia
(F1, 32=9.7, p=0.004), and the interaction between injury and hyp-
oxemia (F1, 32=13.3, p=0.001) had significant impacts on time spent
immobile during the tail suspension testing period. The SHAM group
spent significantly less time immobile than the SHAM+H (p=0.009),
CCI (p=0.0003), and CCI+H (p=0.0004) groups. However, no
difference in time spent immobile was observed between the two CCI
groups, and the effect size was very small (Cohen’s d=0.l8).
Delayed hypoxemia after traumatic brain injury
produces long-term deficits in learning and memory
To determine the impact of delayed hypoxemia on memory and
learning, we conducted Morris water maze tests 6 months post-
injury. No significant effect of either injury status or hypoxemia
was observed on distance to platform or velocity during the visible
training period (Fig. 3A,B). Injury status (F1, 32 = 4.6; p = 0.04) and
interaction of injury status and hypoxemia (F1, 32 = 6.1; p= 0.019)
had significant effects on distance to platform during hidden plat-
form training (Fig. 3C). Post-hoc Tukey’s tests confirmed that the
CCI +H group swam significantly longer distances on average than
both the SHAM +H ( p= 0.012) and CCI ( p = 0.016) groups during
hidden platform training. A large effect size (Cohen’s d = 1.2) of
hypoxemia on distance traveled by CCI mice during hidden plat-
form training was observed. Neither injury status nor hypoxemia
had a significant impact on velocity during the same period of
training (Fig. 3D). The impact of delayed hypoxemia on memory
and learning was further characterized by conduction of a probe
test. Injury status had a significant impact on performance during
the probe trial (F1, 32 = 6.4; p= 0.017; Fig. 3E). The CCI +H group
spent a significantly lower percentage of time in the target quadrant
compared to the SHAM group ( p = 0.03). Although there was not a
statistically significant difference in probe trial performance be-
tween CCI and CCI+H, a moderate effect size was demonstrated
(Cohen’s d= 0.77).
Delayed hypoxemia increases lesion size but does
not reduce hippocampal neuron density
To determine the impact of delayed hypoxemia on lesion vol-
ume, we calculated ipsilateral tissue loss. The CCI+H group had
significantly larger lesion volumes than CCI alone (Fig. 4) with a
large effect size (Cohen’s d= 1.1). Ipsilateral hippocampal volumes
were reduced post-CCI, and a significant injury effect and inju-
ry*hypoxemia interaction effect were demonstrated (Fig. 5).
Table 1. Comparison of Weights and Anesthesia Times between Groups
Sham Sham+Hypoxemia CCI CCI+Hypoxemia Analysis of variance
Weight at time of CCI (g) 18.9 (2.9) 18.0 (2.6) 19.4 (1.5) 19.0 ( 1.6) No difference between groups
Anesthesia time (min) 16.5 (1.3) 15.9 (1.7) 17.9 (2.5) 17.7 (2.2) No difference between groups
Weight at sacrifice (g) 34.0 (3.5) 31.6 (2.5) 32.3 (1.9) 30.6 (1.8)* Hypoxemia F(1,32) = 6.5; p < 0.02
Injury F(1,32) = 2.6; p= 0.12
Injury*Hypoxemia F(1,32) = 1.0; p = 0.67
Values are mean (standard deviation).
*Sham versus CCI+Hypoxemia, post-hoc Tukey, p < 0.03.
CCI, controlled cortical impact.
FIG. 2. Socialization and tail suspension 6 months post-CCI and delayed hypoxemia. (A) Social interaction during a 300-sec test with
a novel 5-week-old male mouse. Socialization was significantly affected by injury status (F(1,32) = 33.4; p= 0.000002) and hypoxemia
(F(1,32) = 17.9; p= 0.0002). The CCI+Hypoxemia group interacted significantly less with the novel mouse than CCI alone. *p< 0.03. (B)
Seconds immobile during 360 sec of tail suspension. Injury status (F(1,32) = 11.3; p= 0.002), hypoxemia (F(1,32) = 9.7; p = 0.004), and the
interaction between injury status and hypoxemia (F(1,32) = 13.3; p = 0.001) had significant effects on time spent immobile. SHAM was
significantly different from the SHAM + Hypoxemia ( p = 0.009), CCI ( p= 0.0003), and CCI+Hypoxemia ( p= 0.0004) groups. *SHAM
significantly different from other groups. CCI, controlled cortical impact.















































Stereological analysis of NeuN-positive cells in the ipsilateral CA3
region of the hippocampus did not demonstrate an additive effect of
hypoxemia on neuronal loss (Fig. 5E). However, stereological
analysis of the contralateral CA3 region of the hippocampus re-
vealed a reduction in NeuN-positive cells in CCI +H (Fig. 5F) and a
reduction in hippocampal volumes post-injury on the ipsilateral
side only (Fig. 5G,H).
Delayed hypoxemia increases astrocytic response
To assess effects of delayed hypoxemia on astrocytic response,
we performed GFAP immunohistochemical staining. GFAP-
positive cell staining was increased by both injury and hypox-
emia (Fig. 6). Injury status (F1, 16 = 64.5; p = 0.000001), hypoxemia
(F1, 16 = 16.2; p= 0.001), and interaction between the two (F1, 16 =
20.0; p= 0.0004) all had significant impacts on level of astrocytic
response. We performed a post-hoc Tukey’s test and confirmed that
the CCI +H group had a significantly higher level of astrocytic
response than the SHAM ( p= 0.0002), SHAM +H ( p = 0.0002), or
CCI ( p = 0.0002) groups.
Delayed hypoxemia has no significant effect
on microglial response
We performed Iba1 immunohistochemical staining to assess
the effect of delayed hypoxemia on long-term microglial response
(Fig. 7). However, only injury status (F1, 15 = 48.7; p = 0.000004)
had a significant impact on level of microglial response. The CCI
group was significantly different from both the SHAM ( p = 0.008)
and SHAM +H ( p = 0.010) groups. The CCI +H group was also
significantly different from the SHAM ( p = 0.0003) and the
SHAM +H ( p = 0.0003) groups. The CCI and CCI +H groups were
not significantly different from each other.
Discussion
To summarize, at 6 months post-injury, we observed deficits in
spatial learning and memory as well as socialization in mice
FIG. 3. Memory and learning deficits six months after injury and delayed hypoxemia. (A) Distance to visible platform was not significantly
different between groups. (B) Velocity to visible platform was not significantly different between groups. (C) Distance to hidden platform
was significantly affected by injury (F(1,32)=4.6; p=0.04) and by the interaction of injury and hypoxemia (F(1,32)=6.1; p=0.019). Post-hoc
Tukey tests confirmed that CCI+Hypoxemia traveled significantly more distance than SHAM+Hypoxemia (p=0.012) and CCI (p=0.016).
(D) Velocity to hidden platform was not significantly different between groups. (E and F) Thirty-second probe trial after 5 days of hidden
platform Morris water maze training. (E) CCI+Hypoxemia spent a significantly lower percentage of time in the target quadrant than the
SHAM group (F(1,32)=6.4; p=0.017, followed by Tukey’s test, p=0.03). (F) Injury had a significant effect on time spent in target zone
(F(1,32)=42.23; p<0.00001). #Compared to SHAM, p<0.003; *compared to SHAM+Hypoxemia, p<0.003. CCI, controlled cortical impact.















































subjected to CCI and delayed hypoxemia. Neuropathological
evaluation at 6 months post-injury demonstrated increased lesion
volume and white matter astrogliosis in mice subjected to CCI and
delayed hypoxemia compared to CCI alone. Together, these data
support the hypothesis that CCI followed by normocarbic hypox-
emia 24 h later exacerbates long-term neuropathology and pro-
duces detectable behavioral deficits 6 months after initial injury.
We did not observe deficits in memory and learning with Morris
water maze testing in mice 6 months after moderate CCI alone
(Fig. 3). However, the addition of 1 h of hypoxemia 1 day post-CCI
resulted in significant behavioral deficits in spatial learning as-
sessed by Morris water maze during hidden platform trials.
Whereas mice undergoing CCI alone were able to perform as well
as sham mice with or without hypoxemia at 6 months, CCI +H
demonstrated longer swim distances throughout the 5 days of
hidden platform testing. Further, CCI +H were the only group to
have a significantly poorer performance on probe trial compared to
SHAM. The Cohen d effect size between CCI and CCI+H was
large during the probe trial, suggesting that slightly larger sample
sizes are needed to appropriately test the hypothesis. With no sig-
nificant differences in swim velocity between the groups, these
observed differences were unlikely attributable to a chronic motor
deficit. To correlate the observed deficits in memory and learning
with neuropathology, we performed histological analysis of the
FIG. 4. Delayed hypoxemia increases lesion volume. (A–D) Exemplars of lesion volume analysis, NeuN staining. Ipsilateral slice area
(red outline) and contralateral slide area (blue outline). Scale bar, 2.5mm. (E) CCI+Hypoxemia had a significantly larger lesion volume
than CCI ( p= 0.002). CCI, controlled cortical impact; NeuN, neuronal nuclei. Color image is available online at www.liebertpub.com/neu















































FIG. 5. NeuN-positive cells in CA3 region of hippocampus. (A–D) Ipsilateral hippocampus. Scale bar, 250 lm. (E) Density of NeuN-
positive cells in the ipsilateral CA3 region of the hippocampus was significantly impacted by injury status (F(1,16) = 39.1; p= 0.0001), but
not by hypoxemia (F(1,16) = 2.1; p = 0.17) or the interaction between injury status and hypoxemia (F(1,16) = 0.128; p = 0.76). *p < 0.02
post-hoc Tukey’s tests. (F) Density of NeuN-positive cells in the contralateral CA3 region of the hippocampus was significantly
impacted by injury status (F(1,16) = 12.8; p= 0.003). *p< 0.05 post-hoc Tukey’s test. (G) Ipsilateral CA3 hippocampal volumes were also
significantly impacted by injury status (F(1,16) = 31.9; p= 0.0001) and the interaction between injury status and hypoxemia (F(1,16) = 7.6;
p < 0.02). *p < 0.02 post-hoc Tukey’s tests. (H) No differences in contralateral CA3 hippocampal volumes. CCI, controlled cortical
















































hippocampus. Hippocampal neurons in the CA3 region are vul-
nerable to death post-TBI, and hippocampal damage has been as-
sociated with poorer performance in Morris water maze
testing.6,28–32 Specifically, hypoxemia immediately post-CCI has
been observed to increase neuronal death in this ROI.6 Stereo-
logical analysis of the CA3 region of the hippocampus with NeuN
immunohistochemistry did not reveal differences in neuron density
between CCI and CCI+H. However, we did observe increases in
lesion volume and decreases in ipsilateral CA3 volume in CCI +H
compared to CCI alone, which is consistent with the behavioral
FIG. 6. Increased astrocytosis 6 months post-injury and delayed hypoxemia. Immunohistochemical staining with GFAP. (A–D) Scale
bar, 500lm. Corpus callosum (CC) and external capsule (EC). (E–G) Scale bar, 100lm. (I–L) Scale bar, 50lm. (M) Astrocytic response
in the CC and EC was significantly impacted by injury status (F(1,16)= 64.5; p= 0.000001), hypoxemia (F(1,16)= 16.2; p= 0.001), and the
interaction between injury status and hypoxemia (F(1,16)= 20.0; p= 0.0004). CCI+Hypoxemia had a significantly higher percent area of
GFAP staining in the ipsilateral CC and EC 6 months post-injury. *p<0.0002, CCI+Hypoxemia compared to each of the other groups using
post-hoc Tukey’s test. (N) Astrocytic response in contralateral CC and EC was significantly impacted by injury status (F(1,16)= 10.6;
p< 0.005) and the interaction between injury status and hypoxemia (F(1,16)= 6.7; p= 0.02). *p< 0.05 using post-hoc Tukey’s test. CCI,
controlled cortical impact; GFAP, glial fibrillary acidic protein. Color image is available online at www.liebertpub.com/neu















































FIG. 7. Microglial response not significantly impacted by delayed hypoxemia. Immunohistochemical staining with Iba1. (A–D) Scale
bar, 500 lm. Corpus callosum (CC) and external capsule (EC). (E–G) Scale bar, 100lm. (I–L) Scale bar, 50lm. (M) Only injury status
had a significant impact on microglial response (F(1,15) = 48.7; p= 0.000004). *p< 0.0003 post-hoc Tukey’s tests. CCI, controlled
















































deficits observed during Morris water maze testing in CCI+H. The
increase in lesion volume after exposure to delayed hypoxemia
supports the hypothesis that delayed hypoxemia exacerbates injury.
Most likely, these observed differences are attributable to expan-
sion of the injury penumbra in the CCI +H group, but we did not
investigate whether the addition of delayed hypoxemia alters
neuronal death or neurogenesis. We hope to perform future in-
vestigations at early time points to quantify neuronal death (Fluoro-
Jade staining) and neurogenesis (bromodeoxyuridine labeling).
Difficulties in social and affective behavior are commonly re-
ported as long-term sequelae in survivors of TBI.33,34 However,
recent studies investigating the efficacy of neuroprotective com-
pounds for TBI have only utilized behavior assessments in the
cognitive and sensoriomotor domains.35–40 We attempted to assess
the stress response utilizing the tail suspension test. Originally
developed to assess the antidepressant activity of pharmacological
agents, the tail suspension test has been utilized to characterize the
phenotypic stress response of different genetic strains of mice.41 At
6 months post-injury, we observed increases in depression-like
behavior in SHAM+H, CCI, and CCI +H compared to SHAM.
Previous investigations have reported greater immobility times in
mice experiencing mild TBI compared to CCI, consistent with our
own findings of small differences in tail suspension between the
groups.42 Interestingly, the effect of hypoxemia alone was signifi-
cant with increased immobility during the tail suspension test. Our
limited immunohistochemical assessments of white matter and the
hippocampus did not reveal significant structural differences be-
tween SHAM and SHAM +H to correlate with these behavioral
observations. It is quite possible that hypoxemia in sham animals
may affect thalamic or hypothalamic pathways unrelated to CCI,
which are responsible for the depression-like findings in
SHAM+H.43–45
Utilizing the social interaction test with younger novel male
mice, we observed decreases in interaction time in all mice who
experienced TBI, similar to what others have found at earlier time
points post-injury.46 CCI +H at 6 months post-injury had signifi-
cantly decreased social interaction compared to the three other
groups. Previous investigations have reported long-term deficits in
socialization in mice experiencing repeated TBIs.42 In our studies,
delayed hypoxemia may be regarded as a ‘‘second hit’’ similar to
repetitive TBI, resulting in increased socialization deficits. Similar
to tail suspension, we also observed a hypoxemia effect on sham
animals. As stated above, the neuropathological correlation to our
behavior findings is unclear, and changes induced by hypoxia in
sham animals may not be detectable by histological assessments.
These results support the use of socialization metrics in future as-
sessments of efficacy for TBI neuroprotection of candidate thera-
peutics and may improve the probability of successful translation to
human trials.
Immunohistochemical assessments of long-term axonal injury in
a CCI model of TBI are difficult given that typical approaches such
as b-amyloid precursor protein and neurofilament axonal swellings
have resolved at much earlier time points.47 As surrogate markers
for white matter injury, we assessed Iba1+ microglia and GFAP+
astrocytes in the ipsilateral corpus callosum and external capsule.
Six months post-injury, stereological analysis of Iba1 immuno-
histochemistry revealed increased microglia density in animals
experiencing CCI compared to SHAM. Long-term microglial ac-
tivation post-TBI has been previously reported in both monkeys
subsequent to experimental focal injury and humans, and our re-
sults are consistent with these previous findings.48,49 Similarly to
our previous findings at 7 days post-injury, we did not observe
statistically significant differences in microglia response between
hypoxemia and normoxemia post-CCI as assessed by Iba1 immu-
nohistochemistry. Assessments of GFAP immunohistochemistry in
the ipsilateral white matter did demonstrate increased astrogliosis
in CCI +H compared to CCI alone, though whether this increase is
a direct response of astrocytes to hypoxia or just a late sequelae or
marker of increased axonal injury is unclear.
Our pre-clinical platform is modeled after observations of severe
TBI patients in our pediatric intensive care unit.11 In our previous
study, the median age of patients experiencing delayed hypoxemia
post-TBI was 12 years. We chose 5-week-old adolescent mice to be
consistent with our previous clinical and pre-clinical investiga-
tions.11 However, our findings may not be generalizable to adult
models. Adolescent mice have been observed to have different
injury patterns and responses to repetitive TBI.50,51 Although all of
our behavioral assessments were performed after the mice had
reached full maturity, the long-term differences in response to CCI
and delayed hypoxemia of the developing versus fully developed
murine brain are unknown. Future studies on adult mice are plan-
ned to determine whether there are age-dependent responses to
delayed hypoxemia.
Our work has implications for future clinically relevant thera-
peutic trials. Specifically, delayed hypoxemia resulting in second-
ary brain hypoxia post-TBI provides a novel target for
neuroprotection that is less subject to the barrier of narrow temporal
windows of efficacy that has plagued the translation of promising
therapeutics from the bench to the bedside in the field of
TBI.18,19,51–54 Patients in the intensive care setting could be rapidly
administered therapeutics after hypoxemic events. It is even fea-
sible to administer exceptionally safe neuroprotective agents pre-
ceding episodes of secondary brain hypoxia in high-risk patients.
Our pre-clinical animal model has quantitative deficits in short-
term neuropathology and long-term behavior to rapidly eliminate
therapeutic candidates unlikely to ultimately succeed and improve
the probability of effective translation to success in human studies.
There are limitations in the experimental design when translat-
ing our findings to clinical TBI. In our model, mice experience a
moderate TBI attributed to limitations with increased mortality
rates at higher levels of injury severity,23 whereas the majority of
TBI patients in the intensive care setting at risk for delayed hyp-
oxemia are classified as severe TBI.11 Our model of hypoxemia
utilizes a 60-min period of moderate hypoxemia. Although we have
previously demonstrated with immunohistochemistry that these
conditions produce brain hypoxia, we have not directly measured
brain tissue oxygen tension in real time as can be done in severe
pediatric TBI patients.55 Another limitation to our murine model is
the lack of cerebral perfusion monitoring during hypoxemia. It is
quite possible that hypotension during hypoxemia could result in
decreased cerebral perfusion pressure, leading to ischemia, an ad-
ditional secondary insult. Future studies in a gyrencephalic model
may be able to illustrate the effects of hypoxemia on systemic blood
pressure, intracranial pressure, and cerebral perfusion pressure, as
well as utilize clinically relevant sedation/anesthetics to more
closely model hypoxemia observed in the intensive care setting.56
To control for possible confounding variables in our behavioral
testing, we were extremely vigilant in randomization, blinding, and
handling all groups uniformly during surgery, hypoxemia, and
behavioral assessments as described in the Methods. Our investi-
gations only included males, and future studies to determine
whether there are any sex-dependent differences in behavioral re-
sponse to delayed hypoxemia are planned. We performed only a
limited battery of behavioral assessments, which do not cover the















































full spectrum of possible behavioral deficits. Future studies will
include assessments of anxiety or disinhibition with open field
exploration and elevated plus-maze, as well as alternative measures
of emotional dysregulation such as forced swim test and sucrose
preference testing.57–60
In conclusion, mice experiencing CCI followed by clinically
relevant delayed hypoxemia were found to have detectable deficits
in socialization, learning, and memory with increased lesion vol-
umes and white matter astrogliosis 6 months after initial injury. Our
model with long-term behavioral deficits and histological findings
provides an attractive TBI platform to assess efficacy of neuropro-
tective compounds targeted at secondary hypoxemia and improve
the successful translation of pre-clinical findings to the bedside.
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